查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2022-2029 年羊膜穿刺针的全球市场
市场调查报告书
商品编码
1169016

2022-2029 年羊膜穿刺针的全球市场

Global Amniocentesis Needles Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概览

在预测期内（2022 年至 2029 年），羊膜穿刺针的全球市场规模预计将以 4.2% 的复合年增长率增长。

羊膜穿刺针在羊膜穿刺术中用于从子宫中取出羊水和细胞以进行检查和治疗。 在怀孕期间，婴儿被羊水包围和保护。 有关婴儿健康的信息由羊膜穿刺术确定。

市场动态

推动全球羊膜穿刺针市场发展的主要因素是全球出生人数的增加以及公众对唐氏综合症和传染病等致命遗传病的认识。 新产品发布的增加有助于羊膜穿刺针市场的增长。

预计出生人数的增加和羊膜穿刺术的普及将推动市场增长。

越来越多地采用羊膜穿刺术诊断遗传疾病、胎儿肺部检测和传染病、怀孕人数增加以及新产品发布数量的增加正在推动羊膜穿刺针市场。 出生人数的增加也推动了市场的增长。 许多医疗保健公司正在加紧研发活动以开发新产品。

羊膜穿刺针用于多种应用，包括基因检测、胎儿输血、胎儿肺部检测、羊水减少程序、羊水过多治疗、经皮脐带取样和胎儿感染诊断。 由于婴儿遗传性疾病的增加，这些应用正在扩大全球市场。 此外，预计主要参与者提供的技术先进的产品也将在市场增长中发挥重要作用。

与设备相关的风险和高成本预计会阻碍市场增长。

存在多种风险，例如羊水渗漏，羊水穿刺后会有少量羊水从阴道漏出。 这种情况很少见，不会影响怀孕。 针刺伤可能导致婴儿将他们的腿或手臂放在针的路径上并受伤。

在孕中期，如果有经验的人在超声波的帮助下进行羊膜穿刺术，流产的风险很小。 它可能引发尿毒症。 Rh 致敏也是婴儿血细胞进入母亲血液引起的并发症。 Rh 阴性母亲被注射 Rh 免疫球蛋白，以防止母亲的身体产生会损害婴儿血细胞的 Rh 抗体。

COVID-19 影响分析

疫情正在对全球金融预期、运营和危机应对策略产生负面影响。 COVID-19 的爆发严重影响了医疗保健行业。 由于 COVID 病例的增加，各种研究和临床试验已经认真开始，羊膜穿刺针市场因 COVID 遭受了巨大损失。 世界各地正在发生各种举措、产品发布、创新、合作和合併，推动了市场的增长。 例如，2021年4月，Medax SRL宣布在印度实现MedOne Ultra和MedEasy的商业化。

内容

第一章研究方法与范围

  • 调查方法
  • 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

第四章市场动态

  • 市场影响因素
    • 司机
      • 出生率增加
      • 孕妇糖尿病患病率增加
      • 羊膜穿刺术的流行率上升
    • 约束因素
      • 羊膜穿刺术费用高
      • 并发症或感染
      • 备选方案的可用性
    • 商机
    • 影响分析

第五章行业分析

  • 波特的五力分析
  • 供应链分析
  • 定价分析

第 6 章 COVID-19 分析

  • COVID-19 市场分析
    • COVID-19 之前的市场情景
    • COVID-19 的当前市场情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格动态
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措
  • 总结

第 7 章按产品类型

  • 100-150mm
  • 超过 150 毫米
  • 小于 100 毫米

第八章应用

  • 羊膜穿刺术
  • 基因检测
  • 胎儿输血
  • 胎儿肺活量测定
  • 羊水消化治疗
  • 烦渴治疗
  • 经皮脐带取样
  • 胎儿感染的诊断

第 9 章最终用户

  • 医院
  • 诊断中心
  • 专科诊所
  • 其他

第10章按地区

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第11章竞争格局

  • 主要发展和战略
  • 公司股票分析
  • 产品基准
  • 值得关注的主要公司名单

第12章公司简介

  • Cooper Surgical Inc.
    • 公司简介
    • 产品组合和说明
    • 主要亮点
    • 财务摘要
  • Cook
  • ICU Medical Inc.
  • Biopsybell
  • Becton, Dickinson and Company
  • Medline Industries LP
  • RI. MOS. Srl
  • Laboratoire CCD
  • Rocket Medical Plc
  • Medax Srl

第13章 DataM

简介目录
Product Code: DMMD1224

Market Overview

The global amniocentesis needles market size was valued at US$ XX million in 2022 and is estimated to reach US$ XX million by 2029, growing at a CAGR of 4.2% during the forecast period (2022-2029).

The amniocentesis needles are utilized for the amniocentesis procedure in which amniotic fluid or cells are removed for testing and treatment from the uterus. The baby is surrounded and protected by amniotic fluid during the pregnancy. Information regarding the baby's health can be determined via amniocentesis.

Market Dynamics

The major factors driving the global amniocentesis needles market are an increase in the number of childbirths across the globe and awareness among the population regarding fatal genetic disorders such as down's syndrome or infections. An increase in novel product launches contributes to the growth of the amniocentesis needles market.

The increasing number of childbirths and increasing adoption of amniocentesis procedures are expected to drive the market's growth.

The rising adoption of amniocentesis procedures for genetic disorders, fetal lung testing and infection diagnosis, an increase in pregnancies, and the rising number of novel product launches drive the amniocentesis needles market. An increase in the number of childbirths is also aiding the market growth. There has been an increase in R&D activities by many healthcare companies to develop novel products.

Amniocentesis needles are used in various applications such as genetic testing, fetal blood transfusion, fetal lung testing, amnioreduction procedure, polyhydramnios treatment, percutaneous umbilical cord sampling, and fetal infection diagnosis. The market for these applications is increasing worldwide due to the increasing number of infant genetic disorders. Moreover, the availability of technologically advanced products by key players is also expected to play a vital role in the market's growth.

Various novel product launches and research studies contribute to the market's growth. For instance, in January 5, 2021, Cooper Surgical, a women's healthcare solution provider, announced its acquisition of Embryo Options, a cryo-storage solutions provider. This acquisition enhances Cooper's innovative fertility product portfolio.

The risks associated with these devices and the high cost are expected to hamper the market's growth.

However, there are several risks faced by the minor population, such as leakage of amniotic fluid in which, after amniocentesis small amount of amniotic fluid starts leaking through the vagina. This is rare and doesn't affect pregnancy. Needle injury is another risk where the baby might bring its leg or arm in the path of the needle that, causes injury.

During the second trimester, there is a little risk of miscarriage in the amniocentesis procedure if done by an experienced person with the help of ultrasound. It can trigger a urine infection. Rh sensitization is also a complication when a baby's blood cells enter the mother's bloodstream. Rh-negative mother is given Rh immunoglobulin injection to prevent the mother's body from making Rh antibodies that can cause damage to the blood cells of the baby.

COVID-19 Impact Analysis

The pandemic has negatively impacted global financial expectations, operations and crisis response strategy. The COVID-19 outbreak has severely impacted the healthcare industry. The amniocentesis needles market has experienced huge losses due to COVID, as various research and clinical trials started in full swing due to the increasing cases of COVID. Various initiatives, product launches, innovations, collaborations and mergers are happening worldwide, boosting the market's growth. For instance, in Apr 2021, Medax SRL announced the commercialization of MedOne Ultra and MedEasy in India.

Segment Analysis

The amniocentesis segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The amniocentesis segment is the largest market shareholder due to its high demand, increasing childbirth and rising adoption of amniocentesis procedures.

A prenatal test named amniocentesis is done for genetic disorders diagnosis. Genetic disorders, including spina bifida and down syndrome and other fetus health issues. Amniocentesis needles are used for amniotic fluid removal in a small amount from the uterus. The lab then tests the amniotic fluid sample for various genetic or chromosomal conditions. This procedure is done during the second or third trimester of pregnancy.

The growing number of regulatory approvals, technological advancements, product launches, and research/clinical trial studies drive the market's growth. For instance, MRD SRL's Amnio needle is a novel stainless steel cannula needle that is disposable and is used for amniotic fluid transabdominal sampling for prenatal diagnosis of the fetus, such as genetic disorders known as amniocentesis. This needle has an echogenic marker that supports correct needle placement in ultrasound guidance. Adjustable stoppers and centimeter markings help to determine the insertion depth.

Geographical Analysis

North America holds the largest market share in the global amniocentesis needles market.

North America dominates the global amniocentesis needles market, primarily due to its large population combined with excellent medical infrastructure and the rising number of childbirth and pregnancies. According to National Centre for Health, in 2022, cancer was the second leading cause of mortality worldwide, with around 1,918,030 new cases registered 2022. Cancer was responsible for 609,360 deaths all over the world. Moreover, as per WHO, the number of new cases is expected to rise by around 70% by 2030.

Increasing expenditure on healthcare and raising awareness among people is also contributing to the market's growth in this region. Advancement of applications of amniocentesis needles in amniocentesis procedures and prenatal diagnostics, such as genetic disorders and fatal infections, increase in pharmaceutical establishment across the region and government approvals, and the presence of key players in the region are contributing to the growth of the amniocentesis needles market.

Moreover, the growing number of product launches is responsible for the market's growth. Many key developments, technological advancements, collaborations, and agreements are taking place in this region. For instance, in Jan 6, 2022, ICU Medical Inc., announced it had completely acquired Smiths Medical from the Smith's Group. Smith's Medical business such as syringes, vital care and vascular access products, and ambulatory infusion devices.

Competitive Landscape

The amniocentesis needles market is moderately competitive with local and global companies' presence. Cooper Surgical Inc., Cook, ICU Medical Inc., Biopsybell, Becton, Dickinson and Company, Medline Industries LP, RI. MOS. Srl, Laboratoire CCD, Rocket Medical Plc, Medax Srl and more. The key players are adopting various growth strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the market's growth. For instance, in Dec 17, 2021, Cooper Companies announced its completion of an acquisition agreement with Generate Life Sciences, a donor egg and sperm provider for fertility treatment and stem cell storage of newborns (cord tissue and blood).

Cooper Surgical Inc.

Overview: Cooper Surgical is a medical device company that focuses on women's and babies' health advancements with its wide products and services portfolio on fertility and genomics, and medical devices. It was established in 1990 and is headquartered in Connecticut, United States.

Product Portfolio:

Wallace Amniocentesis Needles: Wallace is an amniocentesis single-use needle that is provided in sterile packs for the sampling of amniotic fluid. The tip of the needle contains spiral engraving that offers clear visibility.

The global amniocentesis needles market report would provide access to approx. 45 + market data tables, 40 + figures and 200 (approximate) pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Childbirth
      • 4.1.1.2. Prevalence of Diabetes in the Pregnant Woman
      • 4.1.1.3. Increasing Adoption of Amniocentesis Procedures.
    • 4.1.2. Restraints:
      • 4.1.2.1. High Cost of Amniocentesis Procedures
      • 4.1.2.2. Complications or Infections
      • 4.1.2.3. Availability of Substitutes
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1 Porter's Five Forces Analysis
  • 5.2 Supply Chain Analysis
  • 5.3 Pricing Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. 100-150mm *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Larger than 150mm
  • 7.4. Smaller than 100mm

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Amniocentesis *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Genetic testing
  • 8.4. Fetal Blood Transfusion
  • 8.5. Fetal Lung Testing
  • 8.6. Amnioreduction Procedure
  • 8.7. Polyhydramnios Treatment
  • 8.8. Percutaneous Umbilical Cord Sampling
  • 8.9. Fetal Infection Diagnosis

9. By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.1.2. Market Attractiveness Index, By End-User
  • 9.2. Hospitals *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Diagnostic Centers
  • 9.4. Specialty Clinics
  • 9.5. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

  • 11.1. Key Developments and Strategies
  • 11.2. Company Share Analysis
  • 11.3. Products Benchmarking
  • 11.4. List of Key Companies to Watch

12. Company Profiles

  • 12.1. Cooper Surgical Inc. *
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Cook
  • 12.3. ICU Medical Inc.
  • 12.4. Biopsybell
  • 12.5. Becton, Dickinson and Company
  • 12.6. Medline Industries LP
  • 12.7. RI. MOS. Srl
  • 12.8. Laboratoire CCD
  • 12.9. Rocket Medical Plc
  • 12.10. Medax Srl

LIST NOT EXHAUSTIVE

13. Global Amniocentesis Needles Market - DataM

  • 13.1. Appendix
  • 13.2. About Us and End-User
  • 13.3. Contact Us